CS logo
small CS logo
Royal Children's Hospital

Parkville, Victoria, Australia
Hospital in Parkville, Victoria
50 Flemington Rd, Parkville VIC 3052
340 Beds

About Royal Children's Hospital


The Royal Children's Hospital is a major children's hospital in Melbourne, Australia. As a major specialist paediatric hospital in Victoria, the Royal Children's Hospital provides a full range of clinical services, tertiary care, as well as health promotion and prevention programs for children and young people.
There are 340 beds in Royal Children's Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Children's Oncology Group
74
Murdoch Childrens Research Institute
23
National Cancer Institute (NCI)
17
Vertex Pharmaceuticals Incorporated
15
Eli Lilly and Company
8
Pfizer
8
PTC Therapeutics
5
St. Jude Children's Research Hospital
5
Hoffmann-La Roche
4
ReveraGen BioPharma, Inc.
4
Albireo
3
Total Rows: 86

Clinical Trials at Royal Children's Hospital


During the past decade, Royal Children's Hospital conducted 133 clinical trials. In the 10-year time frame, 133 clinical trials started and 59 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 49 clinical trials started and 33 clinical trials were completed. i.e. 67.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years16161313202017171818171716161414223322121244551212998844Started TrialsCompleted Trails2015201620172018201920202021202220230102030
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors
1994-09-01
2007-03-01
Completed
31
Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors
1996-01-01
2006-02-01
Completed
203
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
1995-07-01
2003-08-01
Completed
3,031
Combination Chemotherapy Plus PSC-833 in Treating Children With Refractory or Relapsed Acute Leukemia
1997-01-01
Completed
3
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
1998-04-01
2007-03-01
Completed
69
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
1997-08-01
2011-01-01
Completed
483
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968

Rows per page:

1–100 of 263

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Royal Children's Hospital" #1 sponsor was "Children's Oncology Group" with 74 trials, followed by "Murdoch Childrens Research Institute" with 23 trials sponsored, "National Cancer Institute (NCI)" with 17 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 15 trials sponsored and "Eli Lilly and Company" with 15 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 86 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 77 trials as a collaborator, "Royal Children's Hospital" with 11 trials as a collaborator, "Sydney Children's Hospitals Network" with 5 trials as a collaborator, "Cooperative International Neuromuscular Research Group" with 4 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator. Other collaborators include 146 different institutions and companies that were collaborators in the rest 122 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChildren's Oncology Group: 74Children's Oncology Group: 74Murdoch ChildrensResearch Institute: 23Murdoch ChildrensResearch Institute: 23National CancerInstitute (NCI): 17National CancerInstitute (NCI): 17Vertex PharmaceuticalsIncorporated: 15Vertex PharmaceuticalsIncorporated: 15Eli Lilly and Company: 8Eli Lilly and Company: 8Pfizer: 8Pfizer: 8PTC Therapeutics: 5PTC Therapeutics: 5St. Jude Children'sResearch Hospital: 5St. Jude Children'sResearch Hospital: 5Hoffmann-La Roche: 4Hoffmann-La Roche: 4ReveraGen BioPharma, Inc.: 4ReveraGen BioPharma, Inc.: 4

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 77National CancerInstitute (NCI): 77Royal Children's Hospital: 11Royal Children's Hospital: 11Sydney Children'sHospitals Network: 5Sydney Children'sHospitals Network: 5CooperativeInternationalNeuromuscularResearch Group: 4CooperativeInternationalNeuromuscularResearch Group: 4National Heart, Lung,and Blood Institute(NHLBI): 4National Heart, Lung,and Blood Institute(NHLBI): 4National Institute ofNeurological Disordersand Stroke (NINDS): 4National Institute ofNeurological Disordersand Stroke (NINDS): 4National Institutes ofHealth (NIH): 4National Institutes ofHealth (NIH): 4University of Pittsburgh: 4University of Pittsburgh: 4Boston Children's Hospital: 3Boston Children's Hospital: 3Cystic Fibrosis Foundation: 3Cystic Fibrosis Foundation: 3

Clinical Trials Conditions at Royal Children's Hospital


According to Clinical.Site data, the most researched conditions in "Royal Children's Hospital" are "Cystic Fibrosis" (22 trials), "Leukemia" (14 trials), "Duchenne Muscular Dystrophy" (11 trials), "Sarcoma" (11 trials) and "Neuroblastoma" (8 trials). Many other conditions were trialed in "Royal Children's Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Royal Children's Hospital


Most popular intervention types in "Royal Children's Hospital" are "Drug" (202 trials), "Biological" (49 trials), "Other" (47 trials), "Radiation" (38 trials) and "Procedure" (35 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "Cyclophosphamide" (23 trials), "cyclophosphamide" (22 trials), "Laboratory Biomarker Analysis" (19 trials) and "Etoposide" (18 trials). Other intervention names were less common.

Clinical Trials Genders at Royal Children's Hospital


The vast majority of trials in "Royal Children's Hospital" are 243 trials for "All" genders, 18 trials for "Male" genders and 2 trials for "Female" genders.

Clinical Trials Status at Royal Children's Hospital


Currently, there are NaN active trials in "Royal Children's Hospital". undefined are not yet recruiting, 51 are recruiting, 46 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 144 completed trials in Royal Children's Hospital, 1 suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Royal Children's Hospital, 42 "Phase 1" clinical trials were conducted, 73 "Phase 2" clinical trials and 116 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 11 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 116Phase 3: 116Phase 2: 73Phase 2: 73Phase 1: 42Phase 1: 42Phase 4: 12Phase 4: 12Not Applicable: 11Not Applicable: 11

Created with Highcharts 11.1.0Trials StatusCompleted: 144Completed: 144Recruiting: 51Recruiting: 51Active, not recruiting: 46Active, not recruiting: 46Terminated: 12Terminated: 12Unknown status: 6Unknown status: 6Enrolling by invitation: 2Enrolling by invitation: 2Suspended: 1Suspended: 1Withdrawn: 1Withdrawn: 1

Departments of Royal Children's Hospital


Royal Children's Hospital has several departments that took part in Clinical trials: "Royal Children's Hospital Melbourne - PIN" - 5 trials, "Royal Children'S Hospital; Paediatric Rheumatology" - 3 trials, "Royal Children'S Hospital; Department of Nephrology" - 2 trials, "Royal Children's Hospital Melbourne, Cardiology - Site 5001" - 2 trials